A Phase 2 Study of PNT2258 for Treatment of Relapsed or Refractory B-Cell Malignancies
| Autor: | Harb, Wael a, Lakhani, Nehal J. b, Messmann, Richard c, Klencke, Barbara d, ⁎, Al-Katib, Ayad M. e |
|---|---|
| Zdroj: | In Clinical Lymphoma, Myeloma and Leukemia December 2021 21(12):823-830 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect